Sabine Scheltinga

Title: Sabine Scheltinga: Innovator in Nucleic Acid Purification

Introduction

Sabine Scheltinga is a notable inventor based in Krefeld, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid purification. Her innovative methods have the potential to enhance the efficiency and effectiveness of nucleic acid extraction processes.

Latest Patents

Sabine holds a patent for a nucleic acid purification method. This invention relates to a method for purifying nucleic acids from a sample containing nucleic acids. The method includes several steps: first, bringing the sample into contact with a nucleic acid binding phase that comprises protonatable groups with a pKs value of 9 to 12. Next, the nucleic acids are bound to the nucleic acid phase at a binding pH that is at least one pH unit less than the pKs value of at least one of the protonatable groups. Finally, the nucleic acids are eluted at a pH greater than the binding pH but at least one pH unit less than the pKs value of at least one of the protonatable groups. Additionally, the patent discloses corresponding kits and nucleic acid binding phases that can be utilized for purifying nucleic acids.

Career Highlights

Sabine Scheltinga is currently employed at Qiagen GmbH, a leading company in the field of molecular biology. Her work at Qiagen has allowed her to focus on developing innovative solutions for nucleic acid purification, contributing to advancements in research and diagnostics.

Collaborations

Throughout her career, Sabine has collaborated with several professionals, including her coworkers Roland Fabis and Jan Petzel. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Sabine Scheltinga's contributions to nucleic acid purification exemplify her dedication to advancing biotechnology. Her innovative methods and collaborative spirit continue to influence the field positively.